FDA Clearance Tracker · P100028
FORMULA BALLOON-EXPANDABLE RENAL STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Jan 14, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jan 14, 2011
Approved
Time to decision
179 days
Received Jul 19, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P100028
- Device name
- FORMULA BALLOON-EXPANDABLE RENAL STENT SYSTEM
- Applicant
- Cook Medical Incorporated
- Applicant location
- Bloomington, IN
- Received
- Jul 19, 2010
- Decided
- Jan 14, 2011
- Decision
- Approved
- Supplements
- 4 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- STENT, RENAL (NIN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE FORMULA BALLOON- EXPANDABLE RENAL STENT SYSTEM. THIS DEVICE IS INDICATED FOR USE IN PATIENTS WITH ATHEROSCLEROTIC DISEASE OF THE RENAL ARTERIES FOLLOWING SUB-OPTIMAL PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY (PTRA) OF A DE NOVO OR RESTENOTIC LESION (<= 18 MM IN LENGTH) LOCATED WITHIN 10 MM OF THE RENAL OSTIUM AND WITH A REFERENCE VESSEL DIAMETER OF 4.0 - 7.0 MM. SUPOPTIMAL PTRA IS DEFINED AS >= 50% RESIDUAL STENOSIS, >= 20 MMHG SYSTOLIC OR >= 10 MMHG MEAN TRANSLESIONAL PRESSURE GRADIENT, OR FLOW-LIMITING DISSECTION.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIN. The earliest in FDA's data is P890017, decided Sep 27, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Cook Medical Incorporated
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P140016 · Decided Sep 15, 2015 · 398 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.